Medicared For All Logo

Evelyn Mendoza in Hemet, California

Home California Hemet

Evelyn Mendoza has Hematology/oncology as her primary medical specialty. Their primary office is: 301 N San Jacinto St in Hemet, California.

They're a part of the: Hematology Oncology Consultants medical group which has around 3 members. You can call their office at 951-766-6460 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1984 (around 40 years of experience). They are listed as doing telehealth appointments.


Evelyn Mendoza Office Phone and Directions

Evelyn Mendoza
Hematology Oncology Consultants
301 N San Jacinto St
Hemet, California 92543
951-766-6460


Patient Ratings
Please rate your experience with Evelyn Mendoza below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 951-766-6460


Enter a starting address:


Healthcare Info for Evelyn Mendoza

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1984
The Primary Medical Specialty for Evelyn Mendoza is listed as: Hematology/oncology
Approximate Years of Experience: 40
PAC (PECOS ID)#: 7416020045
NPI #: 1558368605
NPI Created On: 07/05/2005
NPI Last Updated Listed as: 02/05/2009
Primary Taxonomy Code: 174400000X
License Number:
A48611
Listed Gender: Female

Procedures, Services, Charges


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Collection of blood specimen from a completely implantable venous access device
  3. Declotting infusion of implanted central venous access device or catheter
  4. Complete blood cell count (red cells, white blood cell, platelets), automated test
  5. Hydration infusion into a vein 31 minutes to 1 hour
  6. Hydration infusion into a vein
  7. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  8. Infusion into a vein for therapy, prevention, or diagnosis
  9. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  10. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  11. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  12. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
  13. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  14. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  15. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  16. Infusion of chemotherapy into a vein using push technique
  17. Infusion of different chemotherapy drug or substance into a vein
  18. Infusion of chemotherapy into a vein up to 1 hour
  19. Infusion of chemotherapy into a vein
  20. Infusion of different chemotherapy drug or substance into a vein up to 1 hour

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381145

Being Disputed:: No

Product Related: No


Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381147

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381151

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $36

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381153

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381157

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381155

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381159

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381161

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $31

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788381163

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Hematology/oncology Professionals in Hemet

201 N Laursen St
Hemet, CA

301 N San Jacinto St
Hemet, CA
Hematology Oncology Consultants

Providers in Hematology Oncology Consultants

1.Evelyn Mendoza

301 N San Jacinto St
Hemet Ca 92543-3119
Hematology Oncology Consultants
Hematology/oncology

2.Stanley Schinke

301 N San Jacinto St
Hemet Ca 92543-3119
Hematology Oncology Consultants
Hematology

3.Kishore Sehgal

301 N San Jacinto St
Hemet Ca 92543-3119
Hematology Oncology Consultants
Hematology/oncology

4.Kishore Sehgal

28078 Baxter Rd
Murrieta Ca 92563-1403
Hematology Oncology Consultants
Hematology/oncology

View all 3 members of Hematology Oncology Consultants medical group